<SEC-DOCUMENT>0001493152-21-022835.txt : 20210915
<SEC-HEADER>0001493152-21-022835.hdr.sgml : 20210915
<ACCEPTANCE-DATETIME>20210915172829
ACCESSION NUMBER:		0001493152-21-022835
CONFORMED SUBMISSION TYPE:	N-CEN/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20210915
DATE AS OF CHANGE:		20210915
EFFECTIVENESS DATE:		20210915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAXOR CORP
		CENTRAL INDEX KEY:			0000027367
		IRS NUMBER:				132682108
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-CEN/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-22684
		FILM NUMBER:		211256216

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		212-330-8500

	MAIL ADDRESS:	
		STREET 1:		350 5TH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDANT CORP
		DATE OF NAME CHANGE:	19730823
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CEN/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns="http://www.sec.gov/edgar/ncen" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:sccom="http://www.sec.gov/edgar/sccommon" xmlns:ncom="http://www.sec.gov/edgar/ncencommon" xmlns:iso="http://www.sec.gov/edgar/iso_statecodes" xmlns:exch="http://www.sec.gov/edgar/iso_exchangelist" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <schemaVersion>X0404</schemaVersion>
  <headerData>
    <submissionType>N-CEN/A</submissionType>
    <accessionNumber>0001493152-20-003950</accessionNumber>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0000027367</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <flags>
        <returnCopyFlag>true</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
        <confirmingCopyFlag>false</confirmingCopyFlag>
      </flags>
      <investmentCompanyType>N-2</investmentCompanyType>
    </filerInfo>
  </headerData>
  <formData>
    <generalInfo reportEndingPeriod="2019-12-31" isReportPeriodLt12="N"/>
    <registrantInfo>
      <registrantFullName>DAXOR CORP</registrantFullName>
      <investmentCompFileNo>811-22684</investmentCompFileNo>
      <registrantCik>0000027367</registrantCik>
      <registrantLei>984500B839ED8XIK6792</registrantLei>
      <registrantstreet1>350 Fifth Avenue</registrantstreet1>
      <registrantstreet2>Suite 4740</registrantstreet2>
      <registrantcity>New York</registrantcity>
      <registrantzipCode>10118</registrantzipCode>
      <registrantstate>US-NY</registrantstate>
      <registrantcountry>US</registrantcountry>
      <registrantphoneNumber>212-330-8500</registrantphoneNumber>
      <websites>
        <website webpage="www.daxor.com"/>
      </websites>
      <locationBooksRecords>
        <locationBooksRecord>
          <officeName>UBS Financial Services, Inc.</officeName>
          <officeAddress1>200 Park Avenue</officeAddress1>
          <officeAddress2>18th Floor</officeAddress2>
          <officeCity>New York</officeCity>
          <officeStateCountry officeState="US-NY" officeCountry="US"/>
          <officeRecordsZipCode>10166-0005</officeRecordsZipCode>
          <officePhone>212-309-3000</officePhone>
          <booksRecordsDesc>Records relating to custody of fund assets</booksRecordsDesc>
        </locationBooksRecord>
        <locationBooksRecord>
          <officeName>Bank of America</officeName>
          <officeAddress1>P.O. Box 25118</officeAddress1>
          <officeCity>Tampa</officeCity>
          <officeStateCountry officeState="US-FL" officeCountry="US"/>
          <officeRecordsZipCode>33622-5118</officeRecordsZipCode>
          <officePhone>888-287-4637</officePhone>
          <booksRecordsDesc>Records relating to the banking activities of the fund</booksRecordsDesc>
        </locationBooksRecord>
        <locationBooksRecord>
          <officeName>Daxor Corporation</officeName>
          <officeAddress1>350 Fifth Avenue</officeAddress1>
          <officeAddress2>Suite 4740</officeAddress2>
          <officeCity>New York</officeCity>
          <officeStateCountry officeState="US-NY" officeCountry="US"/>
          <officeRecordsZipCode>10118-0022</officeRecordsZipCode>
          <officePhone>212-330-8504</officePhone>
          <booksRecordsDesc>Corporate, governance, financial, legal records, sales literature</booksRecordsDesc>
        </locationBooksRecord>
      </locationBooksRecords>
      <isRegistrantFirstFiling>N</isRegistrantFirstFiling>
      <isRegistrantLastFiling>N</isRegistrantLastFiling>
      <isRegistrantFamilyInvComp>N</isRegistrantFamilyInvComp>
      <registrantClassificationType>N-2</registrantClassificationType>
      <isSecuritiesActRegistration>Y</isSecuritiesActRegistration>
      <directors>
        <director>
          <directorName>Michael Feldschuh</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>Y</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
        <director>
          <directorName>Jonathan Feldschuh</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>Y</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
        <director>
          <directorName>James Lombard</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>N</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
        <director>
          <directorName>Martin S. Wolpoff</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>N</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
        <director>
          <directorName>Edward Feuer</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>N</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
        <director>
          <directorName>Bernhard Saxe, Esq</directorName>
          <crdNumber>N/A</crdNumber>
          <isDirectorInterestedPerson>N</isDirectorInterestedPerson>
          <fileNumbers>
            <fileNumberInfo fileNumber="N/A"/>
          </fileNumbers>
        </director>
      </directors>
      <chiefComplianceOfficers>
        <chiefComplianceOfficer>
          <ccoName>Robert J. Michel</ccoName>
          <crdNumber>N/A</crdNumber>
          <ccoStreet1>350 Fifth Avenue</ccoStreet1>
          <ccoStreet2>Suite 4740</ccoStreet2>
          <ccoCity>New York</ccoCity>
          <ccoStateCountry ccoState="US-NY" ccoCountry="US"/>
          <ccoZipCode>10118</ccoZipCode>
          <ccoPhone>XXXXXX</ccoPhone>
          <isCcoChangedSinceLastFiling>N</isCcoChangedSinceLastFiling>
          <ccoEmployers>
            <ccoEmployer ccoEmployerName="N/A" ccoEmployerId="N/A"/>
          </ccoEmployers>
        </chiefComplianceOfficer>
      </chiefComplianceOfficers>
      <securityMatterSeriesInfo isRegistrantSubmittedMatter="Y">
        <seriesInfo seriesName="N/A" seriesId="N/A"/>
      </securityMatterSeriesInfo>
      <isPreviousLegalProceeding>N</isPreviousLegalProceeding>
      <isPreviousProceedingTerminated>N</isPreviousProceedingTerminated>
      <isClaimFiled>N</isClaimFiled>
      <coveredByInsurancePolicy isCoveredByInsurancePolicy="Y" isClaimFiledDuringPeriod="N"/>
      <isFinancialSupportDuringPeriod>N</isFinancialSupportDuringPeriod>
      <isExemptionFromAct>N</isExemptionFromAct>
      <isUnderwriterHiredOrTerminated>N</isUnderwriterHiredOrTerminated>
      <publicAccountants>
        <publicAccountant>
          <publicAccountantName>Withum Smith+Brown, PC.</publicAccountantName>
          <pcaobNumber>100</pcaobNumber>
          <publicAccountantLei>N/A</publicAccountantLei>
          <publicAccountantCountry>XX</publicAccountantCountry>
        </publicAccountant>
      </publicAccountants>
      <isPublicAccountantChanged>N</isPublicAccountantChanged>
      <isMaterialWeakness>N</isMaterialWeakness>
      <isOpinionOffered>N</isOpinionOffered>
      <isMaterialChange>N</isMaterialChange>
      <isAccountingPrincipleChange>N</isAccountingPrincipleChange>
      <isPaymentDividend>N</isPaymentDividend>
    </registrantInfo>
    <managementInvestmentQuestionSeriesInfo>
      <managementInvestmentQuestion>
        <mgmtInvFundName>Daxor Corporation</mgmtInvFundName>
        <mgmtInvLei>00000000000000000000</mgmtInvLei>
        <isFirstFilingByFund>N</isFirstFilingByFund>
        <numAuthorizedClass>1</numAuthorizedClass>
        <numAddedClass>0</numAddedClass>
        <numTerminatedClass>0</numTerminatedClass>
        <sharesOutstandings>
          <sharesOutstanding sharesOutstandingClassName="Common Stock" sharesOutstandingClassId="C000000000" sharesOutstandingTickerSymbol="DXR"/>
        </sharesOutstandings>
        <fundType>N/A</fundType>
        <isNonDiversifiedCompany>N</isNonDiversifiedCompany>
        <isForeignSubsidiary>N</isForeignSubsidiary>
        <isFundSecuritiesLending>N</isFundSecuritiesLending>
        <didFundLendSecurities>N</didFundLendSecurities>
        <paymentToAgentManagerType>N/A</paymentToAgentManagerType>
        <avgPortfolioSecuritiesValue>N/A</avgPortfolioSecuritiesValue>
        <netIncomeSecuritiesLending>N/A</netIncomeSecuritiesLending>
        <relyOnRuleType>N/A</relyOnRuleType>
        <isExpenseLimitationInPlace>N</isExpenseLimitationInPlace>
        <isExpenseReducedOrWaived>N</isExpenseReducedOrWaived>
        <isFeesWaivedRecoupable>N</isFeesWaivedRecoupable>
        <isExpenseWaivedRecoupable>N</isExpenseWaivedRecoupable>
        <transferAgents>
          <transferAgent>
            <transferAgentName>Continental Stock Transfer &amp; Trust</transferAgentName>
            <transferAgentFileNo>084-00034</transferAgentFileNo>
            <transferAgentLei>N/A</transferAgentLei>
            <transferAgentStateCountry transferAgentState="US-NY" transferAgentCountry="US"/>
            <isTransferAgentAffiliated>N</isTransferAgentAffiliated>
            <isTransferAgentSubAgent>N</isTransferAgentSubAgent>
          </transferAgent>
        </transferAgents>
        <isTransferAgentHiredOrTerminated>N</isTransferAgentHiredOrTerminated>
        <pricingServices>
          <pricingService>
            <pricingServiceName>N/A</pricingServiceName>
            <pricingServiceLei>N/A</pricingServiceLei>
            <pricingServiceCountry>XX</pricingServiceCountry>
            <isPricingServiceAffiliated>N</isPricingServiceAffiliated>
          </pricingService>
        </pricingServices>
        <isPricingServiceHiredOrTerminated>N</isPricingServiceHiredOrTerminated>
        <custodians>
          <custodian>
            <custodianName>Daxor Corporation</custodianName>
            <custodianLei>N/A</custodianLei>
            <custodianStateCountry custodianState="US-NY" custodianCountry="US"/>
            <isCustodianAffiliated>Y</isCustodianAffiliated>
            <isSubCustodian>N</isSubCustodian>
            <custodyType>Self - rule 17f-2 (17 CFR 270.17f-2)</custodyType>
          </custodian>
        </custodians>
        <isCustodianHiredOrTerminated>N</isCustodianHiredOrTerminated>
        <shareholderServicingAgents>
          <shareholderServicingAgent>
            <shareholderServiceAgentName>N/A</shareholderServiceAgentName>
            <shareholderServiceAgentLei>N/A</shareholderServiceAgentLei>
            <shareholderServiceAgentCountry>XX</shareholderServiceAgentCountry>
            <isShareholderServiceAgentAffiliated>N</isShareholderServiceAgentAffiliated>
            <isShareholderServiceAgentSubshare>N</isShareholderServiceAgentSubshare>
          </shareholderServicingAgent>
        </shareholderServicingAgents>
        <isShareholderServiceHiredTerminated>N</isShareholderServiceHiredTerminated>
        <admins>
          <admin>
            <adminName>N/A</adminName>
            <adminLei>N/A</adminLei>
            <adminCountry>XX</adminCountry>
            <isAdminAffiliated>N</isAdminAffiliated>
            <isAdminSubAdmin>N</isAdminSubAdmin>
          </admin>
        </admins>
        <isAdminHiredOrTerminated>N</isAdminHiredOrTerminated>
        <brokerDealers>
          <brokerDealer>
            <brokerDealerName>N/A</brokerDealerName>
            <brokerDealerFileNo>N/A</brokerDealerFileNo>
            <brokerDealerCrdNo>N/A</brokerDealerCrdNo>
            <brokerDealerLei>N/A</brokerDealerLei>
            <brokerDealerCountry>XX</brokerDealerCountry>
            <brokerDealerCommission>0</brokerDealerCommission>
          </brokerDealer>
        </brokerDealers>
        <brokers>
          <broker>
            <brokerName>UBS Financial Services, Inc</brokerName>
            <brokerFileNo>8-016717-8</brokerFileNo>
            <brokerCrdNo>000007654</brokerCrdNo>
            <brokerLei>N/A</brokerLei>
            <brokerStateCountry brokerState="US-NY" brokerCountry="US"/>
            <grossCommission>5275</grossCommission>
          </broker>
        </brokers>
        <aggregateCommission>5275</aggregateCommission>
        <principalTransactions>
          <principalTransaction>
            <principalName>N/A</principalName>
            <principalFileNo>N/A</principalFileNo>
            <principalCrdNo>N/A</principalCrdNo>
            <principalLei>N/A</principalLei>
            <principalCountry>XX</principalCountry>
            <principalTotalPurchaseSale>0</principalTotalPurchaseSale>
          </principalTransaction>
        </principalTransactions>
        <principalAggregatePurchase>0</principalAggregatePurchase>
        <isBrokerageResearchPayment>N</isBrokerageResearchPayment>
        <mnthlyAvgNetAssets>13390039</mnthlyAvgNetAssets>
      </managementInvestmentQuestion>
    </managementInvestmentQuestionSeriesInfo>
    <closedEndManagementInvestment>
      <securityRelatedItems>
        <securityRelatedItem>
          <description>Other</description>
          <securityClassTitle>Common</securityClassTitle>
          <commonStocks>
            <commonStock commonStockExchange="XNYS" commonStockTickerSymbol="DXR"/>
          </commonStocks>
          <otherSecurityDescription>N/A</otherSecurityDescription>
        </securityRelatedItem>
      </securityRelatedItems>
      <isRightsOffering>N</isRightsOffering>
      <secondaryOfferings isSecondaryOffering="Y">
        <secondaryOfferingType>Common stock</secondaryOfferingType>
      </secondaryOfferings>
      <isRepurchaseSecurity>N</isRepurchaseSecurity>
      <isDefaultLongTermDebt>N</isDefaultLongTermDebt>
      <isDividendsInArrears>N</isDividendsInArrears>
      <isSecuritiesModified>N</isSecuritiesModified>
      <managementFee>0</managementFee>
      <netOperatingExpenses>4.11</netOperatingExpenses>
      <marketPricePerShare>9.40</marketPricePerShare>
      <netAssetValuePerShare>3.41</netAssetValuePerShare>
    </closedEndManagementInvestment>
    <attachmentsTab>
      <isLegalProceedings>false</isLegalProceedings>
      <isProvisionFinancialSupport>false</isProvisionFinancialSupport>
      <isIPAReportInternalControl>true</isIPAReportInternalControl>
      <isChangeAccPrinciples>false</isChangeAccPrinciples>
      <isInfoRequiredEO>false</isInfoRequiredEO>
      <isOtherInfoRequired>false</isOtherInfoRequired>
      <isMaterialAmendments>false</isMaterialAmendments>
      <isInstDefiningRights>false</isInstDefiningRights>
      <isNewOrAmendedInvAdvContracts>false</isNewOrAmendedInvAdvContracts>
      <isInfoItem405>false</isInfoItem405>
      <isCodeOfEthics>false</isCodeOfEthics>
    </attachmentsTab>
    <signature registrantSignedName="Daxor Corp" signedDate="2021-09-15" signature="/s/ Robert J. Michel" title="Chief Compliance Officer"/>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INTERNAL CONTROL RPT
<SEQUENCE>2
<FILENAME>independentreport.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 92; width: 280"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and Board of Directors of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daxor
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
planning and performing our audit of the financial statements of Daxor Corporation (the &ldquo;Company&rdquo;), as of and for
the year ended December 31, 2019, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), we considered the Company&rsquo;s internal control over financial reporting, including controls over safeguarding securities,
as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to
comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s
internal control over financial reporting. Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of the Company is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling
this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.
A company&rsquo;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles (GAAP). A company&rsquo;s internal control over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the company are being
made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of a company&rsquo;s assets that could have a material
effect on the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management
or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there
is a reasonable possibility that a material misstatement of the Company&rsquo;s annual or interim financial statement will not
be prevented or detected on a timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consideration of the Company&rsquo;s internal control over financial reporting was for the limited purpose described in the first
paragraph and would not necessarily identify all deficiencies in internal control that might be material weaknesses under standards
established by the PCAOB. However, we noted no deficiencies in the Company&rsquo;s internal control over financial reporting and
its operation, including controls over safeguarding securities, that we consider to be material weakness as defined above as of
December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report is intended solely for the information and use of management and the Board of Directors of the Daxor Corporation and the
Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
12, 2020</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 46; width: 650"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !C 2P# 2(  A$! Q$!_\0
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MBO,)_C3IJ3R)#I5S+&K$*YD"[AZXQQ7:>%?$UMXKT?\ M"VBDB"R&)XWZJP
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MY&?2?^OV'_T,5ZC\:_\ D&:3_P!=I/Y"O+O#G_(SZ3_U^P_^ABO1P'^Y_?\
MJ<&,_P!Z^X^I*\)^,7_(YP_]>2?^A/7NU>+?&?398]:L=3 )@E@\@G' 923^
MH;]#7EY6TL2K]F>CF";H.WD8WPI=5\>VH9@"T4H7W.TG^AKZ"KY-MKF>SN8[
MBVF>&:,[DD1L,I]C7;^$O&7B*^\9:5#=:M<2Q22B-XV(VLIZY'3/OUKT,PP,
MJLO:Q>R_(XL%BXTXJFUN_P ST7XK_P#(AW/_ %VB_P#0J^?J^@?BO_R(=S_U
MVB_]"KY^J\H_@/U?Z$9G_&7H?5.B_P#("T__ *]H_P#T$5S?Q2_Y)_?_ ._%
M_P"C%KI-%_Y 6G_]>T?_ *"*YOXI?\D_O_\ ?B_]&+7B8?\ WF/^+]3UJ_\
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M^N,7_H-=O\%_^18OO^OT_P#H"5Q'Q7_Y'RX_ZXQ?^@UR8?\ Y&,_G^ATUO\
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M\SG<[?B>@]A@5A3_  G\+S3R2B*YCWL6V1S85<]@,=*[%+NWDG6%)5:1H_-
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M=P\IUQCW('/(XK0J:DIRE>IOYE0C&*M'8****@H**** "BBB@ HHHH ****
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%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I .P# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V O<# 2(  A$! Q$!_\0
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M(S[$FB=%1C?FNPC4<G:QT%%%%<YJ%%%% !1110 4444 %%%% !1110 4444
M%%%% !33&AD60HI=00K$<@'K@_@/RIU% !1110 4444 %%%% !1110 4444
M%%%% !4"V5NLT\WE R7 "REN=P&<#GMR>.G)]:GHIWL 4444@"BBB@ HHHH
M0JK%25!*G()'0]/ZFEHHH **** "BBB@ I" <9 .#D9I:* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *.HP:** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ ZC!HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+AT+$SR>8V3T. ./RJF="M3$R'=O:3S/,P-P^??CZ9HT+E&NHKE>NN_X$/\
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
